Recommended 2023 Adult Immunization Schedule Published
Changes include new section relating to COVID-19 vaccines, addition of newly licensed vaccine for hepatitis B
Changes include new section relating to COVID-19 vaccines, addition of newly licensed vaccine for hepatitis B
Findings from an ongoing randomized, placebo-controlled, observer-blind phase 3 trial showed Spikevax was 93.2% effective at preventing COVID-19.
The UK study aimed to investigate SARS-CoV-2 transmission and viral load in vaccinated and unvaccinated people with mild Delta variant infection.
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.